Advanced Enzyme Technologies board to review Q2 financials, trading window closed

Advanced Enzyme Technologies Ltd. has scheduled a board of directors meeting for Wednesday, November 12, 2025. The primary agenda includes considering and approving the un-audited financial results for the quarter and half year ended September 30, 2025, covering both standalone and consolidated figures.

In connection with this, the trading window for dealing in the company's securities, which was previously closed on September 26, 2025, will remain closed until November 14, 2025. This extended closure is to ensure compliance with insider trading regulations ahead of the financial results announcement.

The intimation and notice regarding these events are available on the company's website, www.advancedenzymes.com, as well as on the websites of the stock exchanges, www.bseindia.com and www.nseindia.com.